CLUSTER filed Aug 20, 2026 at 16:05 ET
Three Twist Bioscience insiders, CEO Emily Leproust, President/COO Patrick Finn, and Director Katryn Blake, sold a combined $6.64M in open-market shares over a 7-day window. The CEO's $2.5M sale and the COO's $3.87M sale are the largest, and the cluster represents ~0.07% of the $9.4B market cap, which is below the 0.1% materiality threshold. While the cluster includes multiple C-suite executives, the dollar amount is trivial relative to market cap, and the COO's sales coincide with derivative exercises, suggesting a tax-planning or liquidity motive rather than a bearish signal.